journal article·2012-10-23Open access

Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery

Yin Ren, Sabine Hauert, Justin H. Lo, Sangeeta N. Bhatia

ACS Nano· Volume 6· Issue 10

Abstract

Tumor-targeted delivery of siRNA remains a major barrier in fully realizing the therapeutic potential of RNA interference. While cell-penetrating peptides (CPP) are promising siRNA carrier candidates, they are universal internalizers that lack cell-type specificity. Herein, we design and screen a library of tandem tumor-targeting and cell-penetrating peptides that condense siRNA into stable nanocomplexes for cell type-specific siRNA delivery. Through physiochemical and biological characterization, we identify a subset of the nanocomplex library of that are taken up by cells via endocytosis, trigger endosomal escape and unpacking of the carrier, and ultimately deliver siRNA to the cytosol in a receptor-specific fashion. To better understand the structure-activity relationships that govern receptor-specific siRNA delivery, we employ computational regression analysis and identify a set of key convergent structural properties, namely the valence of the targeting ligand and the charge of the peptide, that help transform ubiquitously internalizing cell-penetrating peptides into cell type-specific siRNA delivery systems.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Harvard−MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Medical Scientist Training Program, Harvard Medical School, Boston, Massachusetts 02115, United States

Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, United States

Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts 02115, United States

Electrical Engineering and Computer Science, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, United States

Funding

Human Frontier Science Program · Howard Hughes Medical Institute · National Cancer Institute

References (32)

Show source-provided references
1. Hopkins A. L. · Nat. Rev. Drug. Discovery · 2002 · 1 · 72710.1038/nrd892 ↗
2. Pecot C. V. · Nat. Rev. Cancer. · 2011 · 11 · 5910.1038/nrc2966 ↗
3. Whitehead K. A. · Nat. Rev. Drug Discovery · 2009 · 8 · 12910.1038/nrd2742 ↗
4. Wolfrum C. · Nat. Biotechnol. · 2007 · 25 · 114910.1038/nbt1339 ↗
5. McNamara J. O. · Nat. Biotechnol. · 2006 · 24 · 100510.1038/nbt1223 ↗
6. Song E. · Nat. Biotechnol. · 2005 · 23 · 70910.1038/nbt1101 ↗
7. Akinc A. · Nat. Biotechnol. · 2008 · 26 · 56110.1038/nbt1402 ↗
8. van den Berg A. · Curr. Opin. Biotechnol. · 2011 · 22 · 88810.1016/j.copbio.2011.03.008 ↗
9. Gump J. M. · J. Biol. Chem. · 2010 · 285 · 150010.1074/jbc.M109.021964 ↗
10. Zorko M. · Adv. Drug Delivery Rev. · 2005 · 57 · 52910.1016/j.addr.2004.10.010 ↗
11. Tan M. · Cancer Res. · 2006 · 66 · 376410.1158/0008-5472.CAN-05-2747 ↗
12. Jiang T. · Proc. Natl. Acad. Sci. U.S.A. · 2004 · 101 · 1786710.1073/pnas.0408191101 ↗
13. Vocero-Akbani A. M. · Nat. Med. · 1999 · 5 · 2910.1038/4710 ↗
14. Sugahara K. N. · Cancer Cell · 2009 · 16 · 51010.1016/j.ccr.2009.10.013 ↗
15. Sugahara K. N. · Science · 2010 · 328 · 103110.1126/science.1183057 ↗
16. Roth L. · Oncogene · 2011 · 31 · 375410.1038/onc.2011.537 ↗
17. Ren Y. · Sci. Transl. Med. · 2012 · 4 · 147ra112
18. Fogal V. · Cancer Res. · 2008 · 68 · 721010.1158/0008-5472.CAN-07-6752 ↗
19. Laakkonen P. · Nat. Med. · 2002 · 8 · 75110.1038/nm720 ↗
20. Pham W. · Chembiochem · 2004 · 5 · 114810.1002/cbic.200400063 ↗
21. Frankel A. D. · Cell · 1988 · 55 · 118910.1016/0092-8674(88)90263-2 ↗
22. Elliott G. · Cell · 1997 · 88 · 22310.1016/S0092-8674(00)81843-7 ↗
23. Derossi D. · J. Biol. Chem. · 1994 · 269 · 1044410.1016/S0021-9258(17)34080-2 ↗
24. Pooga M. · FASEB J. · 1998 · 12 · 6710.1096/fasebj.12.1.67 ↗
25. Montet X. · J. Med. Chem. · 2006 · 49 · 608710.1021/jm060515m ↗
26. Hong S. · Chem. Biol. · 2007 · 14 · 10710.1016/j.chembiol.2006.11.015 ↗
27. Hu Y. · Nano Lett. · 2007 · 7 · 305610.1021/nl071542i ↗
28. Sonawane N. D. · J. Biol. Chem. · 2003 · 278 · 4482610.1074/jbc.M308643200 ↗
29. Maurer-Stroh S. · Trends Microbiol. · 2004 · 12 · 17810.1016/j.tim.2004.02.006 ↗
30. McNaughton B. R. · Proc. Natl. Acad. Sci. U.S.A. · 2009 · 106 · 611110.1073/pnas.0807883106 ↗
31. Belsley, D. A.,Regression Diagnostics: Identifying Influential Data and Sources of Collinearity;Wiley-Interscience:Hoboken, N.J., 2004; pxv.
32. Shah S. · Angew. Chem., Int. Ed. Engl. · 2005 · 44 · 132810.1002/anie.200461458 ↗